Section 56(2)(viib) Valuation Report
Quick answer: Section 56(2)(viib) — the 'angel tax' — taxed share premiums received above fair market value. It was abolished for shares issued on or after 1 April 2024, but it still governs earlier issuances under assessment or appeal, so Rule 11UA valuation reports for past issues remain decisive evidence in pending proceedings.
Looking for expert section 56(2)(viib) valuation report? Virtual Auditor provides practitioner-grade startup valuation services in India, led by CA V. Viswanathan — IBBI Registered Valuer (IBBI/RV/03/2019/12333) | Fellow Chartered Accountant (FCA) | Associate Company Secretary (ACS) | Certified Fraud Examiner (CFE). We combine deep regulatory expertise with hands-on execution to deliver results within your timeline.
What We Deliver
Valuation report compliant with Rule 11UA / Section 56(2)(viib) / FEMA 20(R) — as applicable to your funding round. DCF model with detailed assumptions, revenue projections, and discount rate justification. Monte Carlo simulation output with probability-weighted fair value range. Cap table impact analysis showing pre-money, post-money, and dilution scenarios. Investor-ready executive summary with methodology explanation.
Last reviewed: July 2026 by CA V. Viswanathan (FCA, ACS, CFE, IBBI Registered Valuer)
What Section 56(2)(viib) Taxed — and Why It Is Now Mostly History
Section 56(2)(viib), the notorious "angel tax", treated the excess of share-issue consideration over the fair market value of the shares as the issuing company's income from other sources, taxed at the company's marginal rate. Introduced in 2012 to curb the laundering of unaccounted money through inflated share premiums, it became infamous for catching genuine startups whose commercial valuations — negotiated at arm's length with sophisticated investors — the tax department sought to second-guess using a mechanical Rule 11UA number. For over a decade it was the single biggest tax irritant in the Indian startup ecosystem, generating thousands of demands, appeals and DPIIT-exemption applications.
The provision has now been withdrawn: the Finance (No. 2) Act 2024 abolished Section 56(2)(viib) for shares issued on or after 1 April 2024 (i.e. from AY 2025-26). But abolition is prospective. Every share issued between FY 2012-13 and FY 2023-24 remains within the provision, and assessments, reassessments and appeals for those years continue to run. The valuation report has therefore shifted from a compliance document to a litigation-defence document.
Abolition from 1 April 2024 — What Changed and What Did Not
It is important not to overstate the relief. Abolition removes the specific angel-tax charge on premium going forward, but it does not switch off the surrounding architecture:
| Position | Before 1 Apr 2024 | On/after 1 Apr 2024 |
|---|---|---|
| Premium above FMV taxed in company's hands (56(2)(viib)) | Yes | Abolished |
| Legacy years FY 2012-13 to 2023-24 | Assessable | Still assessable / appealable |
| Receipt below FMV taxed in shareholder's hands (56(2)(x)) | Yes | Continues |
| Transfer below FMV — capital gains (50CA) | Yes | Continues |
| FEMA floor pricing for foreign investors | Yes | Continues |
So a company still needs a defensible valuation for the receipt side, for transfers and for cross-border pricing — see our map of income-tax valuation triggers. What has gone is only the specific charge on issue premium, and only prospectively.
The Legacy Assessment Problem — FY 2012-13 to 2023-24 Still Live
The live risk sits in reassessment. Under the amended Section 148/149 framework, income escaping assessment can be reopened within the extended limitation window where the escaped amount crosses the prescribed threshold — and a large disallowed share premium easily does. Companies that raised at high premiums in 2019-2022 are exactly the cohort now receiving notices. Defending them requires the original, contemporaneous valuation file: the report as it stood on the issue date, the projections that supported it, and the commercial context of the round. Where DPIIT recognition and the eligible-startup declaration (Form 2) were filed, that exemption route is a complete answer for qualifying companies and must be pleaded.
Method Defence — The AO Cannot Simply Swap Your DCF for NAV
The heart of most angel-tax litigation is the assessing officer rejecting a company's DCF and re-computing on NAV — which, for a loss-making startup, collapses the fair value and manufactures a premium. Appellate authorities and tribunals have repeatedly held that this substitution is not open to the AO on a whim:
- Method is the taxpayer's choice. Rule 11UA gives the option of NAV or DCF to the assessee; the AO cannot discard a validly chosen DCF merely because NAV yields a higher tax.
- The valuation date is fixed. The DCF is tested against what was known on the issue date; the AO cannot use later actual results with hindsight to declare the projections unreasonable.
- Scrutiny of assumptions, not rejection of method. The AO may examine the reasonableness of specific inputs and, if genuinely flawed, require correction — but must engage with the model, not replace the entire method.
- Commercial reality carries weight. Where the same shares were subscribed by arm's-length institutional investors at the same price, that is powerful evidence the valuation was not inflated.
Winning these appeals is far more about the quality of the contemporaneous record than about advocacy after the fact.
Building the Evidence File That Survives Scrutiny
Whether defending a legacy year or documenting a pre-April-2024 issue, the file we assemble is designed to close off the AO's standard lines of attack:
- The contemporaneous valuation report — merchant-banker DCF or NAV as chosen, dated on or before the allotment resolution, with method, inputs and rationale disclosed.
- The projection support — the business plan, pipeline, unit economics and board-approved budget underpinning the DCF, showing the numbers were the company's own forward view, not fabricated.
- The commercial trail — term sheet, investor correspondence, cap table and bank statements evidencing arm's-length subscription at the issue price.
- Statutory filings — board resolution, PAS-3, return of allotment and, where available, DPIIT recognition and the Form 2 exemption declaration.
- A variance note — a reasoned explanation of any gap between projection and actual, pre-empting the hindsight argument.
For pre-abolition issues we also reconcile the report with the underlying Rule 11UA workings so method, date and number tell one consistent story.
Fees
| Service | Fee (from) |
|---|---|
| Contemporaneous 56(2)(viib) valuation defence file (per year) | ₹30,000 |
| Method-defence opinion & assumptions note for appeal | ₹40,000 |
| Reassessment (Section 148) response support | ₹50,000+ |
| DPIIT exemption / Form 2 eligibility review | ₹15,000 |
Why Choose Virtual Auditor
We specialise in startup valuations at every stage — pre-revenue, seed, Series A through Series D, and exits. Our 18-method valuation engine handles the unique challenges of early-stage companies: negative cash flows, high growth uncertainty, complex capital structures (SAFEs, convertible notes, CCPS). Led by IBBI Registered Valuer CA V. Viswanathan (IBBI/RV/03/2019/12333) with FCA, ACS, and CFE credentials.
With physical offices in Chennai (Spencer Plaza), Bangalore (MG Road), and Mumbai (Goregaon West), we offer both in-person and remote engagement models.
Pre-revenue and early-stage companies present unique challenges — negative cash flows, hockey-stick projections, and complex capital structures with SAFEs, convertible notes, and CCPS with multiple liquidation preferences. Our approach uses probability-weighted scenario analysis, option pricing for complex instruments, and market-calibrated discount rates. We have valued startups from pre-seed through Series D across SaaS, fintech, healthtech, D2C, and deeptech verticals.
Our Process
Step 1: Initial consultation — funding stage, investor requirements, regulatory framework. Step 2: Cap table review and financial projection analysis. Step 3: Multi-method valuation — DCF, comparable companies, recent transactions, option pricing. Step 4: Draft report review with founders. Step 5: Final report delivery with regulatory compliance certificate.
We understand investor timelines. Our startup valuation reports are structured for investor readability — executive summary first, methodology section, detailed assumptions, and sensitivity analysis. We also prepare cap table impact summaries showing dilution scenarios that founders can share directly with their investors and board.
Get Started Today
Ready to engage Virtual Auditor for section 56(2)(viib) valuation report? Contact us for a free initial consultation:
Call/WhatsApp: +91 99622 60333
Email: support@virtualauditor.in
Offices: Chennai | Bangalore | Mumbai
No obligation. We will assess your requirements and provide a clear scope, timeline, and fixed-fee quote within 24 hours.